Showing results (371-380 of 607) with videos related to
Sort By:
Pageof 61
JACC. Basic to Translational Science|December 14, 2023
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve ReplacementFanny Lassalle, Nicolas Duployez, Flavien Vincent, et al.Journal of Hepatology|December 7, 2023
NIS2+TM as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trialsVlad Ratziu, Stephen A Harrison, Yacine Hajji, et al.EMBO Reports|July 10, 2023
An extended transcription factor regulatory network controls hepatocyte identityJulie Dubois-Chevalier, Céline Gheeraert, Alexandre Berthier, et al.Circulation Research|September 17, 2013
Liver X receptor activation stimulates iron export in human alternative macrophagesGaël Bories, Sophie Colin, Jonathan Vanhoutte, et al.International Journal of Molecular Sciences|May 21, 2015
Adventitial Tertiary Lymphoid Organs as Potential Source of MicroRNA Biomarkers for Abdominal Aortic AneurysmRafaelle Spear, Ludovic Boytard, Renaud Blervaque, et al.Journal of Lipid Research|December 18, 2003
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouseDavid Masson, Bart Staels, Thomas Gautier, et al.The Journal of Biological Chemistry|January 4, 2003
Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in micePablo Mardones, Antoine Pilon, Muriel Bouly, et al.Journal of Cardiovascular Pharmacology|May 9, 2006
Paullinia pinnata extracts rich in polyphenols promote vascular relaxation via endothelium-dependent mechanismsAlexis Zamble, Marie Carpentier, Abdelmejid Kandoussi, et al.Hepatology (Baltimore, Md.)|May 25, 2013
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisBart Staels, Anne Rubenstrunk, Benoit Noel, et al.European Journal of Medicinal Chemistry|June 14, 2017
Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expressionCeline Pirat, Catherine Dacquet, Veronique Leclerc, et al.Pageof 61